STOP The pharmaceutical makers ORGANIZATION and ORGANIZATION said DATE they would delay seeking regulatory approval in the LOCATION and LOCATION for their experimental colon-cancer drug PTK\/ZK after mixed trial results STOP  The delay was a blow to ORGANIZATION which was relying on PTK\/ZK to bolster its earnings and has few drugs in development analysts said STOP  ORGANIZATION 's stock plunged PERCENT to MONEY or MONEY in response to the news STOP  But the shares of ORGANIZATION and ORGANIZATION rallied as their drug MISC which works in a similar way will apparently remain unchallenged for a time STOP 